This is the guidance for information for industry and organisations involved in health and care on preparing for the end of the transition period on 31 December 2020.
New guidance can be found for the following:
This month includes the new edition of National Institute Health Research (NIHR), along with a range of materials, including research from the Covid-19 pandemic.
To read the latest bulletin click here.
This guidance supports Integrated Care Systems and Sustainability and Transformation Partnerships, Primary Care Networks, training hubs and other local partners to understand and continue delivery of the General Practice Fellowship programme, supporting newly-qualified GPs and nurses working in primary care.
The RCOT provides resources and guidelines to plan and structure appropriate therapy, particularly with people recovering from COVID 19. To access their resources and find out more click here.
The LGA, together with the Association for Directors of Public Health, have produced this guide for directors of public health and others leading the response to the loneliness and social isolation issues arising from the Covid-19 pandemic
Read the guide here
This guidance explains how employers and businesses can play their part in the NHS test and trace programme, developed to manage the risk of the virus re-emerging as restrictions on everyday life are eased, as far as it is deemed safe to do so
The government, in consultation with industry, has produced guidance to help ensure workplaces are as safe as possible.
Read the guidance here
This resource focuses on smoking among people living with a broad range of mental health conditions, ranging from low mood and common conditions such as depression and anxiety, to more severe conditions such as schizophrenia and bipolar disorder.
Read the report here
Royal Pharmaceutical Society, February 2019
This guidance is for pharmacists and all healthcare organisations involved with medicine and provides a summary of the scale and complexity of the issue of polypharmacy. The guidance outlines how healthcare professionals, patients and carers can find solutions when polypharmacy causes problems for patients and points to useful resources that can help. The guidance recommends that all healthcare organisations have systems in place to ensure people taking 10 or more medicines can be identified and highlighted as requiring a comprehensive medication review with a pharmacist.
Click here to view the guidance.
Department for Education, Department of Health and Social Care and Home Office, October 2018
This amended guidance on female genital mutilation (FGM) is for all persons and bodies in England and Wales. This guidance is a must read if you are under statutory duties to safeguard and promote the welfare of children and vulnerable adults.
Click here to view the guidance.
